Shannon Kathleen White

Highly motivated, results-oriented, diversely experienced Family Nurse Practitioner committed to clinical excellence and the provision of proactive, age and developmentally appropriate family-centered care. Exceptional ability to multitask; managing numerous, often competing priorities while fostering effective, high quality, culturally sensitive, evidence-based care to each patient and family. Superior interpersonal, communication, relationship-building, presentation, and management reporting skills. Critical thinker with a strong background in interdisciplinary program planning, organizing, coordinating, directing and problem-solving.
 
Before earning her Doctor of Nursing Practice from Waynesburg University, Shannon White received both her Bachelor of Science in Nursing and Master of Science in Nursing from UC. Since 2007, White has been part of a multidisciplinary team in the Headache Center at Cincinnati Children’s Hospital Medical Center. She has helped to further develop the role of the nurse practitioner, has assisted in the development of a nurse practitioner managed acute care infusion unit for patients with an intractable migraine, presented on pediatric headache locally, nationally and internationally, and has been involved as a sub-investigator in numerous industry-sponsored and investigator initiated pediatric headache clinical trials.

Since 2021, she has been an Assistant Professor at the University of Cincinnati teaching in the Doctor of Nursing Practice program. Prior to that, she was Adjunct Faculty since 2019.

 

Doctor Of Nursing Practice: Waynesburg University Pittsburg, PA, 2011 (Focus: Executive Leadership)

Master of Science in Nursing: University of Cincinnati Cincinnati, OH, 2006 (Focus: Family Nurse Practitioner)

Bachelor of Science in Nursing: University of Cincinnati Cincinnati, OH, 2004

Associates of Applied Science: Cincinnati State Technical & Community College Cincinnati, OH, 2002 (Registered Nurse)

Phase 3, multicenter, open-label study to assess the long-term safety and tolerability of rimegepant for the acute treatment of migraine (with or without aura) in children and adolescents

≥ 6 to < 18 years of age. BHV3000-312. IND NUMBER: 109,886. Biohaven Pharmaceuticals Holding Company Limited. Sub-Investigator 2022.

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Comparing the Efficacy, Safety, and Tolerability of Subcutaneous Administration of Fremanezumab Versus Placebo for the Preventive Treatment of Chronic Migraine in Pediatric Patients 6 to 17 Years of Age. TEVA 30082. Sub-Investigator 2021.

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Comparing the Efficacy, Safety, and Tolerability of Subcutaneous Administration of Fremanezumab Versus Placebo for the Preventive Treatment of Episodic Migraine in Pediatric Patients 6 to 17 Years of Age. TEVA 30083. Sub-Investigator 2021

A Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Adolescent Patients 12 to 17 Years of Age with Chronic Migraine – the REBUILD-2 Study. Eli Lilly and Company. Sub-Investigator 2021.
Phase 3, multicenter, open-label study to assess the long-term safety and tolerability of rimegepant for the acute treatment of migraine (with or without aura) in children and adolescents

≥ 6 to < 18 years of age. 2020-003761-18. Biohaven BHV3000-312. Sub-Investigator 2020.
 
Phase 3, multicenter, randomized, double-blind, group sequential, placebo-controlled study to assess efficacy and safety of rimegepant for the treatment of migraine (with or without aura) in children and adolescents ≥ 6 to < 18 years of age. 2020-003517-35. Biohaven BHV3000-311. Sub-Investigator 2020.
 
Multicenter, Open-label, Single-dose Study to Evaluate the Safety, Tolerability and Single-dose Pharmacokinetics of Rimegepant in Children (≥ 6 to < 12 Years of Age) with a History of Migraine. Biohaven BHV3000-121. Sub-Investigator 2020.
 
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 4 Study to Evaluate the Efficacy and Safety of Qudexy® XR in the Prevention of Migraine in Children 6 to 11 Years of Age. Upsher-Smith P255-50. Sub-Investigator 2020.
 
A single arm, open label, multicenter study of the safety and efficacy of Nerivio™ for the acute treatment of migraine in adolescent: 2019-1060: Theranica TCH-004. Research Assistant / Coordinator / Nurse 2019.
 
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Erenumab in Children (6 to <12 Years) and Adolescents (12 to <18 Years) With Chronic Migraine (OASIS PEDIATRIC [CM]): 2019-0933: Amgen_20160354_AMG 334. Sub-Investigator 2019
 
A Phase 3, Randomized, Double-Blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Erenumab in Children (6 to <12 Years) and Adolescents (12 to <18 Years) With Episodic Migraine (OASIS PEDIATRIC [EM]): 2019-0932: Amgen_20150125_AMG 334. Sub-Investigator 2019
 
A Phase I, Randomized, Open-Label, Multiple-Dose Study to Evaluate Safety, Tolerability, and Pharmacokinetics of AMG 334 in Children and Adolescents with Migraine: 2017-3846: AMGEN PK AMG 334_20160172. Sub-Investigator 2018
 
A Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Patients 6 to 17 Years of Age with Episodic Migraine - the REBUILD Study. Sponsor: Eli Lilly and Company. Protocol No. Addendum I5Q-MC-CGAS(1.3). Sub-Investigator 2018.

A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of ONZETRA® Xsail® (Sumatriptan Nasal Powder) for the Acute Treatment of Episodic M

03-2002 -03-2006 Registered Nurse, Provide direct, professional nursing care to the pediatric liver, kidney and bowel transplant, surgery and ENT population in an inpatient setting. Prepare equipment and assist physicians during examinations and treatments. Perform evaluations of new and existing patients to determine priority and suitability of treatment and/or need for modifications. Administer prescribed medications, apply sterile dressings, perform phlebotomy, advocate, educate and monitor vital signs for patients. Maintain confidentiality of patient records. Oversee and guide the work of other nursing and support staff by upholding a charge nurse position. , Cincinnati Children’s Hospital Medical Center, Cincinnati, OH

03-2006 -04-2007 Family Nurse Pracitioner, erform comprehensive patient/family assessment and exam as appropriate for the small bowel and liver transplant population inpatient and outpatient. Perform advanced diagnostic and therapeutic interventions. Formulate plans of care in collaboration with child, family, and a multidisciplinary team. Research and staff education on the small bowel patient population., Children’s Hospital Medical Center, Cincinnati, OH

04-2007 -To Present Family Nurse Practitioner, Family Nurse Practitioner in multidisciplinary, research-based pediatric headache center. Responsible for diagnosis, evaluation, and treatment of children and young adults with headache in both outpatient and acute treatment infusion settings. Experience as sub-investigator and study coordinator in numerous industry sponsored and investigator initiated pediatric headache clinical trials. Presented nationally and internationally on pediatric headache, as well as coauthor of peer-reviewed journals. Research and staff education on the Headache Center patient population., Cincinnati Children’s Hospital Medical Center, Cincinnati, OH

12-2019 -08-2021 Adjunct Faculty, Adjunct Instructor in the College of Nursing. Taught multiple courses when needed in graduate and Doctor of Nursing Practice program., University of Cincinnati, Cincinnati, OH

08-2021 -To Present Assistant Professor, Full time faculty in the College of Nursing. Teaching multiple courses in graduate and Doctor of Nursing Practice program., University of Cincinnati, Cincinnati, OH

Peer Reviewed Publications

Kabbouche, M.A., Powers, S.W., Segers, A., LeCates, S., Manning, P., Cherney, S., Vaughan, P., Burdine, D., & Hershey, A.D (2009. ) Inpatient treatment of Inpatient Treatment of Status Migraine with Dihydroergotamine in Children and Adolescents.Headache, , 49 (1 ) ,106-9 More Information

Slater, S., Crawford, M.J., Kabbouche, M.A., Cherney, S., Vaughan, P., Segers, A., Manning, P., Burdine, D., Powers, S.W., & Hershey, A.D. (2009. ) Effects of Gender and Age on Paediatric Headache.Cephalalgia, , 29 (9 ) ,969-73 More Information

Cobb-Pitstick KM, Hershey AD, O’Brien HL, Kabbouche MA, LeCates SL, White S, Vaughan P, Manning P, Segers A, Bush J, Horn PS, Kacperski J. (2015. ) Factors influencing migraine recurrence after infusion and inpatient migraine treatment in children and adolescents. .Headache, , 55 (10 ) ,1397-1403 More Information

Orr, S, Kabbouche, MA; Horn, P, O’Brien, HL, Kacperski,J, LeCates, SL, White, S, Weberding, J, Miller, M, Powers, SW, Hershey, AD. (2018. ) Predictors of First-Line Treatment Success in Children and Adolescents Visiting an Infusion Center for Acute Migraine .Headache, , 58 (8 ) ,1194-1202 More Information

Orr, Serena L; Turner, Abigail; Kabbouche, Marielle A; Horn, Paul S; O'Brien, Hope L; Kacperski, Joanne; LeCates, Susan; White, Shannon; Weberding, Jessica; Miller, Mimi N; Powers, Scott W; Hershey, Andrew D (2020. ) The Profile and Prognosis of Youth With Status Migrainosus: Results From an Observational Study.Headache, , 60 (5 ) ,878-888 More Information

Orr, Serena L; Turner, Abigail; Kabbouche, Marielle A; Horn, Paul S; O'Brien, Hope L; Kacperski, Joanne; LeCates, Susan; White, Shannon; Weberding, Jessica; Miller, Mimi N; Powers, Scott W; Hershey, Andrew D (2019. ) Predictors of Short-Term Prognosis While in Pediatric Headache Care: An Observational Study.Headache, , 59 (4 ) ,543-555 More Information

Martin, Vincent T; Allen, Janelle R; Houle, Timothy T; Powers, Scott W; Kabbouche, Marielle A; O'Brien, Hope L; Kacperski, Joanne; LeCates, Susan L; White, Shannon; Vaughan, Polly; Mandell, Karen; Hershey, Andrew D (2018. ) Ovarian hormones, age and pubertal development and their association with days of headache onset in girls with migraine: An observational cohort study.Cephalalgia : an international journal of headache, , 38 (4 ) ,707-717 More Information

Lax, Daniel N; White, Shannon; Manning, Paula; Kabbouche Samaha, Marielle (2023. ) Diagnostic Algorithm for Pediatric Headaches: A Clinical Improvement Initiative.Pediatric neurology, , 149 ,108-113 More Information

Ghosh, Ankita; Horn, Paul S; Kabbouche Samaha, Marielle; Kacperski, Joanne; LeCates, Susan L; White, Shannon; Powers, Scott W; Hershey, Andrew D (2023. ) Characterization of Migraine in Children and Adolescents With Generalized Joint Hypermobility: A Case-Control Study.Neurology. Clinical practice, , 13 (5 ) ,e200188 More Information

Invited Presentations

Shannon White (05-13-2010. ) An Introduction to Pediatric Headache .West Virginia Nurse Practitioner Conference, Huntington, WV. Level:State

Shannon White (04-04-2019. ) Pharmacologic Management of Pediatric Headaches .21st annual Advanced Practice Provider Conference , Mason, Ohio. Level:Regional

Shannon White (01-2018. ) Headaches in School Aged Children .Hamilton County School District School Nurse Conference, Cincinnati, OH. Level:Local

Shannon White (11-2016. ) Headaches in School Age Children .School Nurse Conference at Drees Pavilion, Cincinnati, OH. Level:Local

Shannon White (10-2014. ) School Nurses Role in Recognizing and Treating Childhood Migraine .School Nurse Conference at Xavier University, Cincinnati, OH. Level:Regional

Shannon White (10-2013. ) Diagnosis and Treatment of Pediatric Migraine .Advanced Practice Provider Conference , Cincinnati, OH. Level:Regional

Shannon White (10-27-2022. ) Medical Management of Headaches .O’Grady Psychology Resident Didactic , Cincinnati Children's Hospital Medical Center. Level:Local

Shannon White (03-16-2022. ) Treatment of Headaches .APN Pharmacology Series, Cincinnati Children's Hospital Medical Center. Level:Local

Shannon White (11-04-2021. ) Medical Management of Headaches .O’Grady Psychology Resident Didactic , Cincinnati Children's Hospital Medical Center. Level:Local

Shannon White (02-2020. ) Diagnosis and Treatment of Pediatric Migraine .FNP Class, Xavier University. Level:University

Shannon White (2014. ) Prescriptive Practices in Ohio .Transition to Practice for new Cincinnati Children’s Hospital Medical Center APRN’s every other month, Cincinnati Children's Hospital Medical Center. Level:Department

Shannon White (2015. ) Prescriptive Practices in Ohio .Transition to Practice for new Cincinnati Children’s Hospital Medical Center APRN’s every other month, Cincinnati Children's Hospital Medical Center. Level:Department

Shannon White (2016. ) Prescriptive Practices in Ohio .Transition to Practice for new Cincinnati Children’s Hospital Medical Center APRN’s every other month, Cincinnati Children's Hospital Medical Center. Level:Department

Shannon White (04-13-2015. ) IV Acute Treatment of Pediatric Migraine .Same Day Surgery RNs , Cincinnati Children's Hospital Medical Center. Level:Department

Shannon White (10-2014. ) Changing the Outcome for Children with Migraine .Family Nurse Practitioner Class, University of Cincinnati. Level:University

Shannon White (02-21-2012. ) Headaches… You Can’t Cure Them But You Sure Can Make Them Better .APN Pharmacology Series, Cincinnati Children's Hospital Medical Center. Level:Local

Shannon White (10-18-2011. ) What Should I Know About Prescribing in Ohio as and APN? .APN Pharmacology Series, Cincinnati Children's Hospital Medical Center. Level:Local

Shannon White (10-19-2010. ) How Do I Prescribe As An APN in Ohio .APN Pharmacology Series, Cincinnati Children's Hospital Medical Center. Level:Local

Shannon White (05-06-2010. ) Changing the Outcome for Children with Migraine .O’Grady Psychology Resident Didactic , Cincinnati Children's Hospital Medical Center. Level:Department

Shannon White (10-21-2009. ) How to Prescribe to Pediatric Patients in Ohio .APN Pharmacology Series, Cincinnati Children's Hospital Medical Center. Level:Local

Shannon White, Mandi Cafasso (10-09-2007. ) What do I need to know to prescribe medications? .APN Pharmacology Series, Cincinnati Children's Hospital Medical Center. Level:Local

Shannon White (08-08-2007. ) Nurses: Changing the Outcome for Children with Migraines .Nursing Grand Rounds, Cincinnati Children's Hospital Medical Center. Level:Local

Shannon White (09-2017. ) Primary Headache Diagnosis Algorithm .International Headache Society Conference, Vancouver, Canada. Level:International

Shannon White (06-26-2010. ) Diagnosis & Acute Treatment of Pediatric Migraine .AANP 25th National Conference, Pheonix, Arizona. Level:National

Shannon White (10-19-2023. ) Medical Management of Headaches. Invited speaker .O'Grady Psychology Resident Didactic , Cincinnati Children's Hospital Medical Center. Level:Local

Shannon White (05-09-2024. ) Management of Pediatric Headache .Advanced Pharmacy Series for Prescribers, Cincinnati Children’s Hospital Medical Center. Level:Regional

Poster Presentations

Shannon White (06-23-2011. ) Headache Response Rates in an Acute Care Infusion Unit for Primary Intractable Headache in Children .15th International Headache Congress, Berlin, Germany. . Level:International

Kabbouche, M.A., Powers, S.W., Segers, A., LeCates, S., Manning, P., Cherney, S., Vaughan, P., Burdine, D., & Hershey, A.D (06-23-2011. ) Vitamin D deficiency Among Pediatric Patients with Recurrent Headaches .15th International Headache Congress, Berlin, Germany. . Level:International

Shannon White (05-18-2012. ) Response rates of pediatric primary intractable headache to acute infusion therapies .American Pain Society, Honolulu, Hawaii. . Level:National